Comparison of Customized and Standard Facemasks for Early Treatment of Class III Malocclusion

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-12
SponsorAzienda Ospedaliero-Universitaria Careggi

About this trial

The aim of the study is to compare a customized facemask for the treatment of Class III malocclusion in the prepubertal growing patient (patients between the ages of 5 and 12 years) versus a standard commercial facemask. Specifically, preference, pain, difficulty in sleeping, time of use, and possible complications for the two types of facemasks will be analyzed.

This is a single-center, national, controlled, superiority, randomized, crossover, open-label study.

Each patient will be treated with both the customized facemask and the standard commercial facemask. Each patient will wear one type of facemask for 2 months and the other type of facemask for the next 2 months. After 2 weeks and at the end of therapy with each of the facemask types, the patient, with the possible help of the parents, will have to answer a questionnaire about pain and difficulty sleeping and report any complications. In addition, after completing both phases (fourth month), the patient should indicate a preference for one of the two types of mask with which to complete therapy for an additional 6 months.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 5 and 12 years;

Class III malocclusion, for which early orthopedic treatment with rapid maxillary expander and facemask is indicated.

signing of informed consent

Disqualifiers

Cleft lip and/or palate.

Craniofacial syndromes.

Trial design

Design model

Crossover

Treatments tested in this trial

  • Customized facemask

    Device

    The customized face mask will be fabricated from a 3D digital image of the patient's face obtained by means of a 3D scanner. Such a scanner consists of 6 digital SLR cameras and software capable of processing a 3-D image of the patient's face exportable as an stl file.

  • Standard facemask

    Device

    The standard facemask is the commercially available Petit standard facemask

Treatment groups

24 Participants
are divided into 2 treatment groups
Group A: Customized facemaskExperimental treatment 1 intervention
Group B: Standard facemaskActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Questionnaire on the preference of the patient for one of the two types of face masks

The primary endpoint is a questionnaire on the preference between the two types of face masks at the end of the second phase of therapy (4 months after delivery of the first face mask)

Time frame
4 months

Secondary outcomes

1

Pain reported by patients

Pain measured through Visual Analogue Scale with minimum value of 0 and maximum value of 10. Higher scores mean worse pain.

Time frame
At 2 weeks and at 2 months after delivery of each of the 2 face masks
2

Difficulty in sleeping reported by patients

Difficulty in sleeping measured through VAS Visual Analogue Scale with minimum value of 0 and maximum value of 10. Higher scores mean more difficulty in sleeping.

Time frame
At 2 weeks and at 2 months after delivery of each of the 2 face masks
3

Number of complications

Number of complications

Time frame
At 2 weeks and at 2 months after delivery of each of the 2 face masks
4

Total time wear

Total time wear measured with a thermosensor (Theramon)

Time frame
At 2 months after delivery of each of the 2 face masks

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: